Rheumatology practices can combat declining reimbursements with ancillary services. Experts discuss adding infusion, ultrasound & research services to boost revenue & patient care.
Search results for: osteoporosis
8 Tips for Hiring and Keeping the Best Employees for Your Practice
Even if you hire human resources professionals, as a private practice owner, you still want to have a good grip on the basics of attracting great people to your practice and keeping them happy. Speakers at ACR Convergence 2025 shared pearls to help practice owners do just that.
Complicated Cases Discussed in Pediatric Thieves Market
At this ACR Convergence 2025 session, clinicians discussed complex and difficult-to-diagnose pediatric cases.
Complementary Medicine Meets Rheumatology: New Ways to Reduce Inflammation
At this ACR Convergence 2025 session, the speaker highlighted ways complementary and alternative medicine can be used alongside traditional medical treatments.
3 AC&R Study Summaries: RA & Frailty, Hydroxychloroquine Can Protect Kidneys in Lupus Nephritis, & PT for Knee OA
Research on PT for knee OA, HCQ’s protective role in lupus nephritis & the link between RA disease activity & frailty.
What’s New in Psoriatic Arthritis?
Dr. David Pisetsky curated the research presented at ACR Convergence 2025 and answers the question “What new research on psoriatic arthritis has the potential to impact patient care or future research?”
FDA Approves 2 More Denosumab Biosimilars
The FDA as approved the biosimilar treatments denosumab-nxxp (Bildyos) and denosumab-nxxp (Bilprevda) for all indications of denosumab, their reference product, including osteoporosis in postmenopausal women.
Countdown to ACR Convergence 2025: Early Registration Ends Aug. 21
Learn about the registration options and add-on opportunities associated with ACR Convergence 2025, to be held Oct. 24–29 in Chicago, Ill.
Biosimilar Update: 2025 Brings More FDA Approvals & Interchangeability
Here is a brief recap of the latest FDA-approved biosimilar agents, highlighting their reference products and interchangeability.
New Editor in Chief Has Expansive Vision for Arthritis & Rheumatology
Incoming Arthritis & Rheumatology Editor-in-Chief Dr. S. Louis Bridges Jr., MD, PhD, discusses his path to rheumatology and outlines his vision for the journal.
- « Previous Page
- 1
- …
- 6
- 7
- 8
- 9
- 10
- …
- 59
- Next Page »